2009 annual financial data
Innate Pharma 2009 Operating margin
Direct answer
Operating margin was -201.33%.
Operating income was -15,535,000 EUR and net income was -14,626,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,716,000 EUR
- Operating income
- -15,535,000 EUR
- Net income
- -14,626,000 EUR
- Operating cash flow
- Not available